Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
The New England Journal of Medicine
|
June 15, 2026
Immunosuppression-Associated Peripheral T-Cell Lymphoma
Edward Robert Scheffer Cliff, Melita Kenealy
Expert Review of Anticancer Therapy
|
October 20, 2007
Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents
Mark Bishton, Melita Kenealy, Ricky Johnstone, et al.
Leukemia & Lymphoma
|
September 20, 2012
Treatment of chronic myelomonocytic leukemia with azacitidine
Eric Wong, John F Seymour, Melita Kenealy, et al.
Leukemia & Lymphoma
|
December 17, 2021
Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia
Zoe K McQuilten, Ljoudmila Busija, John F Seymour, et al.
Haematologica
|
November 4, 2006
Treatment-related myelodysplasia following fludarabine combination chemotherapy
Constantine S Tam, John F Seymour, H Miles Prince, et al.
Ejhaem
|
November 29, 2023
Favorable outcomes of <i>DDX41</i>-mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide
Ing S Tiong, William S Stevenson, Meaghan Wall, et al.
European Journal of Haematology
|
December 28, 2021
Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS)
Lynette Chee, David Ritchie, Mandy Ludford-Menting, et al.
Leukemia & Lymphoma
|
October 27, 2006
Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy
Steven W Lane, Julie Crawford, Melita Kenealy, et al.
Leukemia & Lymphoma
|
June 9, 2016
Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML)
Melita Kenealy, Nigel Patton, Robin Filshie, et al.
Leukemia & Lymphoma
|
October 30, 2009
IgA nephropathy associated with cutaneous T cell lymphoma
Ashish Bajel, Ming Yin Lin, Prudence A Hill, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
The New England Journal of Medicine
|
June 15, 2026
Immunosuppression-Associated Peripheral T-Cell Lymphoma
Edward Robert Scheffer Cliff, Melita Kenealy
Expert Review of Anticancer Therapy
|
October 20, 2007
Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents
Mark Bishton, Melita Kenealy, Ricky Johnstone, et al.
Leukemia & Lymphoma
|
September 20, 2012
Treatment of chronic myelomonocytic leukemia with azacitidine
Eric Wong, John F Seymour, Melita Kenealy, et al.
Leukemia & Lymphoma
|
December 17, 2021
Hemoglobin is a key determinant of quality of life before and during azacitidine-based therapy for myelodysplasia and low blast count acute myeloid leukemia
Zoe K McQuilten, Ljoudmila Busija, John F Seymour, et al.
Haematologica
|
November 4, 2006
Treatment-related myelodysplasia following fludarabine combination chemotherapy
Constantine S Tam, John F Seymour, H Miles Prince, et al.
Ejhaem
|
November 29, 2023
Favorable outcomes of <i>DDX41</i>-mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide
Ing S Tiong, William S Stevenson, Meaghan Wall, et al.
European Journal of Haematology
|
December 28, 2021
Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS)
Lynette Chee, David Ritchie, Mandy Ludford-Menting, et al.
Leukemia & Lymphoma
|
October 27, 2006
Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy
Steven W Lane, Julie Crawford, Melita Kenealy, et al.
Leukemia & Lymphoma
|
June 9, 2016
Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML)
Melita Kenealy, Nigel Patton, Robin Filshie, et al.
Leukemia & Lymphoma
|
October 30, 2009
IgA nephropathy associated with cutaneous T cell lymphoma
Ashish Bajel, Ming Yin Lin, Prudence A Hill, et al.
Page
of 2